Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mesenchymal stem cells: progress toward promise.

K Le Blanc1, Mf Pittenger

  • 1Department of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden.

Cytotherapy
|July 26, 2005
PubMed
Summary

Adult stem cells, particularly mesenchymal stem cells (MSC), are preferred for cellular therapeutics due to practical advantages over embryonic stem cells. Their isolation, expansion, and compatibility offer significant therapeutic opportunities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Grading of minor salivary gland immuno-histopathology post-allogenic hematopoietic cell transplantation.

Heliyon·2023
Same author

Quantitative chromogenic immunohistochemical image analysis in cellprofiler software.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2018
Same author

Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation.

Bone marrow transplantation·2015
Same author

A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation.

Journal of internal medicine·2013
Same author

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.

Leukemia·2012
Same author

Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.

Stem cells (Dayton, Ohio)·2012

Area of Science:

  • Regenerative Medicine
  • Cellular Therapeutics
  • Immunology

Background:

  • Laboratories often prioritize adult stem cells over embryonic stem cells for practical reasons in developing cellular therapeutics.
  • Mesenchymal stem cells (MSC) are multipotent cells isolated from adult tissues, commonly from bone marrow (BM).
  • Adult stem cells offer advantages like ease of isolation, expansion potential, and stability for therapeutic applications.

Purpose of the Study:

  • To review recent developments in the field of adult stem cells, focusing on mesenchymal stem cells (MSC).
  • To highlight the advantages of MSC for developing cellular therapeutics.
  • To discuss the investigation of allogeneic MSC interactions with the immune response and their application in cardiovascular medicine.

Main Methods:

Related Experiment Videos

  • Isolation and characterization of multipotent adult stem cells.
  • Examination of MSC multipotency and stability.
  • Investigation of allogeneic MSC interactions with the immune system.

Main Results:

  • MSC possess practical advantages for cellular therapeutics, including ease of isolation, expansion potential, stable phenotype, shippability, and formulation compatibility.
  • Allogeneic MSC interactions with the immune response are under investigation for therapeutic potential.
  • MSC show promise for applications in cardiovascular medicine.

Conclusions:

  • Mesenchymal stem cells (MSC) represent a significant scientific and therapeutic opportunity.
  • The practical advantages of MSC make them highly suitable for current cellular therapeutic development.
  • Continued research into MSC, including their immunomodulatory properties and cardiovascular applications, is warranted.